Applying dynamic combinatorial chemistry (DCC) to medicinal chemistry projects can be a helpful strategy for finding starting points in the drug-discovery process. As relevant drug target, 14-3-3 proteins play a role in several diseases and many biological processes. Proteins of this family engage in protein-protein interactions (PPIs), and can up-or down-regulate their binding partner's activity. Another family of relevant targets are glucansucrases, which are important enzymes in the initiation and development of cariogenic dental biofilms, commonly known as dental plaque. In the last two chapters, endothiapepsin was used for protein-templated DCC (ptDCC). Endothiapepsin belongs to the family of the aspartic proteases, which are involved in for example the maturation of the HIV virus particle.
Throughout this thesis, we focus on applying DCC to various projects. The main achievements are: 1) the description of the in-house protocol of DCC, in which aspects like solubility of building blocks and products, protein stability and more need to be taken in to account, 2) the application of acylhydrazone-based DCC to two targets, a (PPI)-target and a glucansucrase, 3) the identification of smallmolecules, which stabilise PPIs of 14-3-3/ synaptopodin, 4) expanding the reaction toolbox of ptDCC by two additional reactions: nitrone and thiazolidine formation. 
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